Key result
Strict glycemic control is linked to ~3-fold higher incidence of subclinical AF despite lower arterial stiffness.
Why the study?
While poor glycemic control promotes arterial stiffening in patients with diabetes and heart failure, its longitudinal relationship with device-detected subclinical atrial fibrillation (SCAF) remained unclear.
Does strict glycemic control (HbA1c <7.0%) compared to inadequate glycemic control (HbA1c ≥7.0%) affect arterial stiffness and device-detected subclinical atrial fibrillation in patients with type 2 diabetes and heart failure with implanted cardiac devices?
Cohort (n=86)
No
Does strict glycemic control (HbA1c <7.0%) compared to inadequate glycemic control (HbA1c ≥7.0%) affect arterial stiffness and device-detected subclinical atrial fibrillation in patients with type 2 diabetes and heart failure with implanted cardiac devices?
In patients with diabetes and heart failure with implanted cardiac devices, poor glycemic control (HbA1c ≥7.0%) is associated with increased arterial stiffness, whereas strict control (HbA1c <7.0%) is linked to a nearly three-fold higher incidence of subclinical atrial fibrillation, highlighting the need for individualized glycemic targets.
Answers are grounded in this paper and cite their sources.
Strict control linked to higher SCAF despite lower stiffness; leaves open optimal HbA1c targets in diabetic HF with devices.
Background Diabetes mellitus and heart failure frequently coexist and contribute to vascular remodeling and arrhythmogenesis. While poor glycemic control promotes arterial stiffening, its relationship with device-detected subclinical atrial fibrillation (SCAF) remains unclear, particularly in longitudinal settings. Objectives To evaluate the impact of glycemic control on arterial stiffness and SCAF in patients with diabetes and heart failure with implanted cardiac devices. Methods In this prospective observational study, 86 patients with heart failure and type 2 diabetes were stratified by baseline HbA1c into strict control (< 7.0%, n = 29) and inadequate control (≥ 7.0%, n = 57). Carotid–femoral pulse wave velocity (cf-PWV) and device-detected arrhythmias were assessed at baseline and 6 months. Group comparisons and regression analyses were performed using standard statistical methods. Results Baseline cf-PWV was higher in the inadequate control group [12.0 (9.7–15.0) vs. 9.4 (8.6–11.8) m/s; p = 0.009], remaining higher at follow-up (p = 0.002). cf-PWV correlated with HbA1c (r = 0.250, p = 0.01) and diabetes duration (r = 0.296, p = 0.006). Change in PWV did not differ between groups (p > 0.05). SCAF incidence was greater in the strict control group (27.6% vs. 8.8%; p = 0.029). Patients with SCAF had lower baseline HbA1c (6.9 ± 0.7% vs. 7.9 ± 1.5%; p = 0.004). No difference was observed in ventricular arrhythmias or ICD therapies (p > 0.05). Conclusion Poor glycemic control is associated with increased arterial stiffness, whereas strict control is linked to higher SCAF incidence in diabetic heart failure. These findings support individualized glycemic targets balancing vascular protection and arrhythmic risk.
No takes yet. Share an insight, caveat, or question.
Durmaz et al. (2026) conducted a cohort in Heart failure and type 2 diabetes mellitus (n=86). Strict glycemic control (baseline HbA1c <7.0%) vs. Inadequate glycemic control (baseline HbA1c ≥7.0%) was evaluated on Device-detected subclinical atrial fibrillation (SCAF, atrial rate ≥190 bpm for >6 minutes) (p=0.029). Strict glycemic control had lower baseline arterial stiffness but higher 6-month subclinical AF incidence than HbA1c ≥7.0%.
Synapse has enriched 10 related papers. Consider them for comparative context: